Shows
Frazis Capital Podcast#94: Nvidia’s Red Flags, NeoCloud Bubble & the Quiet Quant Crash0:00 – Intro0:42 – Nvidia earnings: strong growth but odd details2:10 – Circular Nvidia deals: inventories, AR and “not-real” revenue4:40 – Retail mania: quantum computing, nuclear & Aussie drone stocks7:05 – When the music stops: 60–80% drawdowns in retail favourites9:05 – NeoClouds explained: ex-Bitcoin miners turned AI GPU landlords12:05 – Hyperscalers, Nvidia vs AMD and why GPU economics may crack14:00 – Gemini 3 vs ChatGPT & other models – real edge or hype?16:40 – How AI tools are changing developer workflows and markets18:20 – Frazis’ quant models, 73.5%/82% returns & trading the rips21:10 – CTA flows, max-long to max-short and a trillion in fast money23:40 – Discretionary stocks smashed: Chipotle, Six Flags, Nike & the consumer25:40 – Current positioning: cash levels, biotech pain & healthcare winners27...
2025-12-2838 minFrazis Capital Podcast#95 Year-End Market: AI CapEx, Nvidia, Neo-Clouds & 2026 Setup | Frazis Capital PodcastWhy markets look “fine” but small caps are quietly crashingThe brutal 50 - 60% wipeouts in quantum, nuclear & neo-cloud stocksHow 2025 became a one-way market dominated by AI & semiconductorsAI CapEx, rate expectations, and why headlines are driving everythingOpenAI vs Google Gemini vs Claude, who’s actually winning the AI race?The uncomfortable truth about Nvidia demand and “financed revenue”Neo-clouds explained: why leasing GPUs may signal weakness, not strengthThe looming AI oversupply risk nobody wants to talk aboutWhy hyperscalers (Microsoft, Amazon) al...
2025-12-2343 minFrazis Capital Podcast#93: Retail Driving Red-Hot Rally & the $10B Quest for the Holy Grail: Can Grail Change Cancer Detection?0:00 – Intro: Mike & Ellianna catch up after Melbourne investor meetings0:45 – Market update: Retail investors driving a red-hot rally2:15 – Quants, institutions, and semiconductors hitting profit targets3:40 – Why Frazis Capital is rotating into healthcare4:30 – Spotlight on Grail: $10B spent chasing a pan-cancer blood test6:10 – The Pathfinder 2 trial and physician skepticism7:40 – FDA approval, adoption challenges, and cash burn9:00 – Clarity Pharmaceuticals: $203M raise and bold head-to-head trial10:40 – Lessons from biotech cycles: Intellia’s 100% rebound12:10 – Quant signals, timing, and managing risk in volatile markets13:40 – Retail euphoria vs. institutional lag — what...
2025-10-1023 min
The Graduate Dentist PodcastTroubleshooting & Decision Making with Dr Michael FrazisFor those of you who follow me on Instagram, you’ll know I’ve been documenting my journey this year as I undertake RipeGlobal’s Fellowship in Restorative Dentistry. Being in my third year of practice— having navigated many of the trials and tribulations of being a new grad—I felt it was time to take on something more long-term, with built-in accountability and structured progress tracking. I wanted something to help me evaluate my clinical skills, see where my strengths and flaws lie, and fill in the gaps in my knowledge I’d hadn't given the time nor had the reso...
2025-06-091h 41Frazis Capital PodcastEquity sell off - the real deal? Strategy update from Michael FrazisEquity sell off - the real deal? Strategy update from Michael Frazis
2025-03-2234 minFrazis Capital Podcast#79 Breakout data in Myelofibrosis - Syntara CEO Gary Philips joins to discuss their breakout resultsTakeawaysSyntara's recent data suggests significant improvements in myelofibrosis patients.The company has a unique in-house drug development model.Syntara's drug 5505 shows promise in reducing fibrosis.The clinical trial results indicate a high percentage of responders.There is a substantial unmet need in the treatment of myelofibrosis.Syntara is exploring additional indications for their drug.Investor relations are crucial for funding future studies.The market opportunity for Syntara's drug is significant.The company is focused on maintaining a strong safety profile for their drug.Future studies will aim to expand the understanding of 5505's efficacy.Chapters00...
2024-12-141h 01Frazis Capital Podcast#78 - Immutep CEO Marc Voigt discusses the latest in immunotherapy for lung cancerMichael Frazis interviews Marc Voigt, CEO of Imutep, discussing the challenges of lung cancer, the evolution of immunotherapy, and the innovative approaches Imutep is taking in cancer treatment. They explore clinical trial data, commercial opportunities, and advancements in autoimmune disease research, while also addressing the financial health and future directions of Immutep.
00:00 Introduction to Lung Cancer and Its Challenges
02:32 Understanding Treatment Options for Lung Cancer
05:22 The Evolution of Immunotherapy
08:00 Imutep's Innovative Approach to Cancer Treatment
10:39 Clinical Trials and Promising Data
13:47 Collaboration with Merck and Future Prospects
25:48 Clinical Trials and Efficacy Analysis
28:03 Commercial Opportunities in Oncology
31:15 Acquisition Trends in Biotech
31:38...
2024-11-3051 minFrazis Capital Podcast#77: Healthcare crash, Chrome vs Perplexity and a new business ideaMichael Frazis and Arjun Balaji discuss the current state of the markets, the shifts in healthcare and the performance of small-cap tech stocks. They analyze the challenges faced by major pharmaceutical companies like Pfizer and Moderna, particularly in light of political changes and scrutiny. The discussion also delves into the role of advertising in the pharmaceutical industry, the impact of AI tools on research and investment strategies, and the potential of proprietary and synthetic data in AI development. The conversation concludes with thoughts on the future of search engines and the unique data advantages held by companies like Tesla.
2024-11-2238 min
Equity Mates Investing PodcastExpert: Michael Frazis - Ozempic, semiconductors, AI & the next big biotech Today’s guest is Michael Frazis, founder of Frazis Capital Partners. Michael is noted for his growth-investing framework searching for companies that are fast growing with deep customer love. He joins us today to unpack what he’s seeing in biotech, semiconductors, AI and GLP-1 drugs. With his fund up 74% so far this year - he’s obviously seeing a fair bit! You don't want to miss this episode. —------Want to get involved in the podcast? Record a voice note or send us a messag...
2024-10-3145 min
The Rate Of Change#33 - Michael Frazis | Where to for Big Tech, Chip Makers, A.I. & Life Sciences? Michael Frazis is the Managing Director and Portfolio Manager of Frazis Capital Partners, which has a focus on companies with explosive growth potential predominately in the Tech and life sciences space.Michael and I discuss a variety of fascinating topics, from his fund’s 80% performance this year (as of time of recording) to his thoughts on navigating the tech and biotech sectors. We dive into key stocks like Nvidia, DroneShield, Clarity Pharmaceuticals, Mercado Libre, Newbank and TransMedics.We also explore Michael’s AI-backed risk management tool, which has been integral in lock...
2024-09-109h 14Equity Mates Investing PodcastExpert: Michael Frazis - Why I sold NvidiaToday’s guest is Michael Frazis, founder of Frazis Capital Partners. Michael is one of the most well-known growth investors in Australia, with his fund returning 80% in the first half of 2024. Over the past 5 years, he has ridden many of the up's and down's of investing in technology and life sciences and in today's episode he unpacks how he managed it and what he has learned. In today’s episode we cover: Michael's investing philosophyHow his growth fund rode the high's of 2020 and 2021 and the low's of 2022 and 2023What he has changed from...
2024-07-0845 minFrazis Capital Podcast#69: Droneshield: Defending against the modern horrors of war, with CEO Oleg VornikIt must be a uniquely modern horror to see a drone flying towards you with a grenade strapped, and it must be all the worse to know your last moments are being filmed.
Drones are now ubiquitous across the battlefields of Ukraine, Gaza, and shipping lanes in the Middle East. Costing relative pittances, cheap drones loaded with explosives can destroy military hardware worth millions, or in the case of ships, billions of dollars.
They can combine in swarms to overwhelm even the most advanced defence systems, and mask deadlier missiles and weaponry.
This ne...
2024-05-301h 01Frazis Capital PodcastFrazis Capital PodcastSemis, Tesla and interest rates, what we're looking at right now
2024-04-0521 minFrazis Capital PodcastFrazis Capital Podcast #64: Clarity Pharmaceuticals, chipmakers, and a chart doing the roundsFrazis Capital Podcast #64: Clarity Pharmaceuticals, chipmakers, and a chart doing the rounds
2024-03-2626 minFrazis Capital PodcastFrazis Capital Podcast #63: The three revolutions of 2023 and where they will go in 2024.The three revolutions of 2023 and where they will go in 2024.
And our top ASX pick...
2024-01-2322 minFrazis Capital PodcastFrazis Capital Podcast #62: Medtech, liquidity, and talking computersMedtech, liquidity, and talking computers
2023-10-1714 minFrazis Capital PodcastFrazis Capital Podcast #61: Bond yields hit cycle highs, medtech takes a GLP-pounding, Nvidia and Microsoft do some cool science, and all roads in semiconductors lead to TSMC.Bond yields hit cycle highs, medtech takes a GLP-pounding, Nvidia and Microsoft do some cool science, and all roads in semiconductors lead to TSMC.
2023-10-0637 min
The Rate Of Change#12 - Michael Frazis | Unpacking Global Growth, Tech & Life SciencesMichael Frazis is the Managing Director and Portfolio Manager of Frazis Capital Partners.Keen listeners will remember Michael from last year and we wanted to have him back on to see how the fund has been doing over the past year. Michael also unpacks what he is looking at in the Tech and biotech space as well as discussing a new AI backed risk management tool he has built to help in lock in future profits.I really enjoyed this conversation and I encourage you to listeners to the disclaimer at the end of this...
2023-09-181h 00Frazis Capital PodcastDouble or Nothing #14: Michael Frazis and Misha Saul talk marketsDouble or Nothing #14: Michael Frazis and Misha Saul talk markets
2023-04-0220 minFrazis Capital PodcastDouble or Nothing #13: Submarines and Silicon Valley BankMichael Frazis and Misha Saul talk Silicon Valley bank and Submarines
2023-03-1729 minFrazis Capital PodcastFrazis Capital Update - 9 February 2023Michael Frazis gives an update on markets and technology.
2023-02-0927 minFrazis Capital PodcastDouble or Nothing #11: Chess, inflation, AI, software, stocksMisha Saul and Michael Frazis talk markets
2023-02-0139 minFrazis Capital PodcastDouble or Nothing #9: Grindr IPO, Sunrise, and inflation rolls over0:12 – Latest (deflationary) inflation data
6:42 – Investing strategies
10:30 – Tesla’s journey and the switch to self-driving capabilities
12:56 – David Walsh’s presentation at Sohn Conference on professional gambling
14:46 – Grindr IPO
21:36 – Recap of Blackbird’s Sunrise startup conference and thoughts on private markets
31:44 – Lessons learned from market downturns
38:25 – Cyclicality of the semiconductor industry
39:31 – Life science industry outlook
2022-11-2541 minFrazis Capital PodcastDouble or Nothing #8: SBFMichael Frazis and Misha Saul talk SBF and inflation.
2022-11-1542 minFrazis Capital PodcastDouble or Nothing #7: Nuclear war? And Facebook, Square, Microsoft, GoogleDouble or Nothing #7: Nuclear war? And Facebook, Square, Microsoft, Google
2022-10-0957 minFrazis Capital PodcastDouble or Nothing #6: Run on the pound? And private equity does dealsMisha Saul and Michael Frazis discuss latest developments in global markets.
2022-10-0145 minFrazis Capital PodcastDouble or Nothing #5: Adobe buys Figma, Ancient and Modern heroes, and CPI printsDouble or Nothing with Michael Frazis and Misha Saul.
Adobe buys Figma, Ancient and Modern heroes, and CPI prints
2022-09-1644 minFrazis Capital PodcastDouble or Nothing #4: Kim Kardashian's private equity play, the collapse in US gas prices, Twilio, Whitehaven and VC0:32 – Passing of Queen Elizabeth II
7:35 – Kim Kardashian’s new private equity play
9:16 – Collapse in price of crude oil
13:12 – Market and inflation outlook
15:32 – Twilio
21:19 – Whitehaven Coal
24:37 – Update on VC Fund deals
32:02 – Summary and wrap-up
2022-09-1132 minFrazis Capital PodcastDouble or Nothing #3: Artificial intelligence gets creative and Powell speaks at Jackson HoleArtificial intelligence gets creative and Powell speaks at Jackson Hole
2022-09-0247 minFrazis Capital PodcastDouble or Nothing #2: Qantas, NVDA, Farfetch, Nathan Tinkler and FortescueDouble or Nothing with Misha Saul and Michael Frazis
0:15 – Preview and thoughts on Jerome Powell’s upcoming speech
1:00 – Update on Nvidia’s recent earnings and the wider semiconductor industry
12:10 – Farfetch update and latest earnings
15:45 – Notable small cap and GARP stocks
17:23 – Qantas recent performance and share buyback announcement
22:46 – Nathan Tinkler’s proposed coal mine acquisition
26:31 – Texas government order for divestment of all Blackrock holdings due to hostility on fossil fuels
28:06 – Andrew Forrest’s rise in the mining industry
34:05 – Assessment of Farfetch’s success and...
2022-08-2949 minFrazis Capital PodcastNew Format with Misha Saul. Double or Nothing Episode #1Trialling a new format, and joined by Misha Saul. Please let us know what you think!
2022-08-201h 01
The Rate Of Change#2 - Michael Frazis | Finding growth in global technology and life sciencesMichael Frazis is the founder and portfolio manager at Frazis Capital Partners. Frazis Capital Partners is an Australian based fund manager that specialises in global growth investments, technology and life sciences.Murdoch discusses with Michael their two strategies. The main Frazis fund, which invests in listed fast growing global growth companies and secondly the Frazis Venture Fund, which invests in emerging, unlisted, early stage or pre-IPO growth opportunities also in technology and the life sciences space.In this ROCast we explore the dramatic volatility we have seen recently in global growth assets, the impact it...
2022-08-1745 minEquity Mates Investing PodcastEarnings wrap + Michael Frazis on his growth portfolioEarning Season continues ... and so does this Equity Mates content train. So, so much in this episode.The market has had a good week ... so, are we out of the woods? Is it blue skies, unicorns and rainbows from here?Alec and Bryce do a fast track market wrap to give you a solid run down of the past week's company earnings results.The lads are joined by Michael Frazis, founder of Frazis Capital Partners, to get his view on current markets and more of an understanding of small cap growth stocks...
2022-08-0745 min
Frazis Capital PodcastEpisode #60: Market update - 15 May 2022Michael Frazis gives a market update. Detailed notes to follow.
2022-05-1848 minFrazis Capital PodcastEpisode #59: A cure for Dystonia with Dr Stephen TischAn interview with Dr Stephen Tisch, who is researching treatment methods for dystonia at St Vincent's Hospital, Sydney.
If you would like to support Neurology and Neurosciences Research at St Vincent’s please visit www.supportstvincents.com click Donate, and select 'Neurosciences Research' from the drop-down menu.
Or contact Nicole at the St Vincent’s Curran Foundation on +61 422 715 377 or by Email nicole.forrestgreen@svha.org.au for EFT-bank details and cheque instructions.
2022-04-1645 min
The R & J YarnFund Manager - Michael FrazisTo kick off the year we sat down for an interview with Sydney based fund manager Michael Frazis who leads Frazis Capital Partners. It's a fascinating insight into the world of fund management and investing, plus we hopefully have provided insights into the key investment themes for 2022. Listen in and be inspired for your investing.
2022-01-0957 minFrazis Capital PodcastEpisode #58: Equity rotation and the tech sell-offStrategy update recorded live on 22 December 2021
(Timestamps to follow)
2022-01-0733 minFrazis Capital PodcastEpisode #57: Misha Saul on markets, life, family, and violence in Western societyMisha Saul on markets, life, family, and violence in Western society
2021-12-031h 35Frazis Capital PodcastEpisode #56: Market reviewMichael Frazis reviews the market.
1:35 – Fallen angels & Fed balance sheet taper 3:53 – Comments on Coupa 7:26 – Lightspeed 8:35 – Teladoc 13:15 – Twilio 14:40 – Roku 18:10 – Upstart 19:16 – EBR Systems 20:40 – PayPal and Visa 24:52 – Coupang 29:50 – Thoughts on inflation 31:46 – Question #1: Sea Limited 32:12 – Question #2: Comments on mid-cap growth companies that haven’t fallen 32:42 – Question #3: Portfolio outlook 36:22 – Question #4: Crypto for payments 38:07 – Question #5: Matterport 38:45 – Question #6: Additional question on Upstart 39:33 – Question #7: Comparison of current revenue multiples to early 2000’s 43:40 – Question #8: Update on Regeneron and the Biotech sector 47:51 – Question #9: PayPal vs. Square
2021-11-2949 minFrazis Capital PodcastEpisode #55: Inflation strikes1:00 – Thoughts on the recent inflation data from the US
3:06 – The 6% differential between the Fed funds rate and inflation, and its impact on the economy
4:31 – Parallels with inflation spikes in the seventies and nineties
7:36 – The effect of inflation on the Australian dollar
7:46 – The effect of inflation on companies – Cloudflare
9:00 – Comments on Lightspeed
9:43 – Comments on Cettire
10:27 – Comments on Upstart
15:35 – Thoughts on Opendoor’s recent results and Zillow’s exit
17:47 - Roblox’s continued explosive growth and its impact on the Metaverse
19:05 – Thoughts on MercadoLibre’s recent results
19:59 – Our number one pick in the crypto space – Galaxy Digital
21:07 – Two crypto coins that you can stake – Olympus and KlimaDAO
22...
2021-11-1734 minFrazis Capital PodcastEpisode 54: New venture fund, Web3, Zillow vs Opendoor, and questions answered0:58 Launch of our Venture Fund
3:04 The benefits of pre-IPO access and our investment in Camplify
4:58 Private access to fast growing companies like Mawson Infrastructure
6:05 Zillow’s shrinking growth model
11:05 Comparative management decisions between Opendoor and Zillow
15:54 More on Zillow’s travails and management
17:29 The importance of customer love – Tesla
18:25 Tesla valuation thoughts
19:16 The NFT and crypto revolution
23:40 How crypto is transforming how games are played
27:48 Facebook’s lame Metaverse
29:53 The exciting prospects of games like Star Atlas
30:55 Our thoughts on Pinduoduo and Coupang
31:47 Chinese capital controls and its effe...
2021-11-0652 min
CPD Junkie Dental PodcastDr Michael FrazisMEET DR MICHAEL FRAZIS
Dr Michael Frazis graduated in 2012 and he spent the first few years of his career focusing on patient communication and expanding his basic skill set. He now enjoys all aspects of dentistry, with a particular interest in cosmetic work, complex surgery and managing complex nervous patients.
Michael is a frequent contributor to multiple online dental forums and is a lead educator globally for RipeGlobal. He has is involved with teaching dentists of all ages in a variety of live and cloud based courses around the world.
Enjoy as Dr Lau...
2021-10-141h 05Frazis Capital PodcastEpisode 53: How to build a deep tech company in aerospace from scratch, with Henry Bilinsky, founderCEO of MicroTauHenry joins us to talk about his journey and experiences with surface science, engineering, and the US Airforce.
Timestamps
0:35 – How did MicroTau come to be?
2:08 – Henry discusses his involvement with InnoCentive challenges
5:16 – A challenge from the US Air Force Research Laboratory
6:26 – What is drag?
8:26 – How riblets found on shark skin can reduce drag
11:20 – Printing with light to create nano-scale features on surfaces
15:14 – Henry talks about his unexpected success with the US Air Force challenge
17:54 – Submitting a business proposal to the US Air Force
...
2021-09-2351 minFrazis Capital PodcastEpisode 52: 20 September 2021 Update and Questions AnsweredMichael Frazis gives an update and answers questions.
0:26 – Introduction
1:10 – Performance update
1:58 – Comments on the NASDAQ100’s strong rally
2:46 – The performance of small-mid cap companies
3:38 – An analyse of where our returns have come from over the years
4:20 – Our past investment in bluebird bio
5:39 – Our IPO/pre-IPO investments in the life sciences
6:57 – We funded a PhD fellowship on research into Dystonia
8:45 – True customer love and explosive growth
9:14 – Our take on ESG and the rising coal prices
10:40 – The effects of currency f...
2021-09-2141 minFrazis Capital PodcastEpisode 51: New antibodies, vaccines, and our portfolio companies Cettire, Futu, and Camplify reportTimestamps
0:15 Introduction to our strategy
2:55 How a company can lose money and still create value
4:38 Avoiding ‘deep value’ traps
5:30 Update on 2021 fund performance
6:50 How we’re investing in China
9:00 Update on FUTU’s Q2 results and why we bought more
12:18 Recently approved antibodies for COVID-19 – cause for optimism?
16:23 Update on Cettire’s FY21 results
18:03 How we evaluate business ‘quality’
19:00 Update on Camplify’s FY21 results
21:18 Question: thoughts on Digital Turbine
22:39 Question: thoughts on the recent Square and Afterpay deal
2021-09-0224 minFrazis Capital PodcastEpisode 50: Reporting season and the next big thing in the life sciencesMichael Frazis gives an update
2021-08-2349 minFrazis Capital PodcastEpisode 49: Regulatory crackdown in China and Square's acquisition of AfterpayMichael Frazis gives an update.
2021-08-0628 minFrazis Capital PodcastEpisode 48: SALT interview with Rachel Pether - true love and explosive growthMichael Frazis describes his investment company’s strategy that involves a 30-40 year view, not panicking and diverting the approach during dips and rallies. Evaluating growth stocks involves identifying customer love for a product or service which acts a key indicator of explosive growth potential. This approach is utilized in picking winners in industries like the ‘buy now, pay later’ space. Frazis explains how vaccine development is a long process involving extensive trials and how the emergency approval of Moderna’s vaccine allowed the company to prove the mRNA concept, providing the company a significant boost.
TIMESTAMPS
0:00...
2021-07-1939 min
SALT TalksMichael Frazis: True Love & Explosive Growth | SALT Talks #232Michael Frazis is a Managing Partner and Portfolio Manager at Frazis Capital Partners. Frazis Capital Partner's Frazis Fund beat both the S&P/ASX 200 and MSCI World Total Return Index by over 100% net in 2020. Over the past 12 months, the fund has generated returns of 188%. Prior to founding the firm, Michael spent five years in private equity in London, after completing internships in Goldman Sachs Special Situations Group and the Boston Consulting Group. Michael read Chemistry at Oxford University, and has a Masters of Finance from the London School of Economics. At Oxford, Michael’s research focused on the...
2021-06-3039 minFrazis Capital PodcastEpisode 47: A disastrous decision from the FDAMichael Frazis attempts to understand the FDA's decision to approve Biogen's aducanumab for Alzheimer's and the possible ramifications.
2021-06-1013 minFrazis Capital PodcastEpisode 46: Strategy in the Life SciencesTimestamps
· 0:32 – Our fast-growing portfolio companies
· 2:21 - Frazis life sciences strategy update
· 5:18 – RNAi Biology
· 7:15 – Alnylam: RNAi clinical development pipeline and recent execution
· 8:16 – Timing and valuation in life sciences
· 9:26 – What do we think of CRISPER?
· 11:03 – Companies targeting sickle cell disease
· 11:56 – Companies targeting beta-thalassemia
· 12:53 – Platform technologies: Moderna
· 15:12 – Platform technologies: Ultragenyx
· 16:30 – Special focus: Alzheimer’s
· 18:50 –Alzheimer’s APOE4
· 23:50 – Could Alzheimer’s be caused by infection?
· 24:55 – Cortexyme: Alzheimer’s and the gingivalis hypothesis
· 27:00 – Cassava and Alzheimer's
· 28:30 – How are we different to Ark?
· 29:10 – Summary
2021-06-0631 min
Chris Judd's Talk Ya Book PodcastMichael FrazisIn this episode of Talk Ya Book, we’re joined by founder and Portfolio Manager of Frazis Capital Partners, Michael Frazis. After an impressive 2020 - returning north of 100% for his long-only international equities fund - we get to hear more about his investing strategy and one of his favourite stocks at the moment, Moderna (NASDAQ: MRNA). Proudly presented by Spirit Technology Solutions.See omnystudio.com/listener for privacy information.
2021-05-1819 minFrazis Capital PodcastEpisode 45: Growth sell-off continuesMichael Frazis discusses the growth sell-off in equities as of 15 May 2021.
2021-05-1727 min
Frazis Capital PodcastEpisode 44: Dr Robert StretchDr. Robert Stretch is a specialist in Pulmonary, Critical Care & Sleep Medicine.
After graduating from Yale School of Medicine in 2014, he completed subspecialty training at BIDMC, a Harvard teaching hospital in Boston, and UCLA Medical Center in Los Angeles.
Timestamps
0:05 – Introducing Robert Stretch
0:25 – Robert’s journey studying medicine in the US
3:40 – Findings when working on the MIMIC (Medical Information Mart for Intensive Care) database at MIT University
9:31 – Robert’s move into sleep apnoea
12:23 – What is sleep apnoea?
16:47 – What are the main risk factors for developing s...
2021-05-101h 04
The Dental Head Start PodcastTIP #44: Saving Every Tooth But At What Cost? with Dr Michael Frazis
Welcome to What I Wish I Knew by Dental Head Start. This is a podcast where we learn from people that have been there, made the mistakes, learnt the lessons and have developed into the accomplished dental professionals they are today.
It’s your weekly mentoring session.
We’ve all be in that situation where we’re torn between saving a tooth and throwing in the towel. As with all things in dentistry, there isn’t necessarily a correct answer. Ultimately, what’s most important is how we go about explaining the situation and presenting the option...
2021-05-0525 minFrazis Capital PodcastEpisode 43: Strategy update 22 April 20210:15 – Introduction to Frazis Capital Partners.
1:45 – Sell-off trends and SPAC’s.
3:57 – Growth stocks outperforming tech indices.
6:45 – Standpoint on growth stocks.
9:18 – Software’s strong run.
11:05 – Multiple contractions and what this means.
13:30 – Teladoc Health.
14:20 – View on Appharvest.
16:45 – Batteries & developments in the lithium space.
18:30 – Thoughts on DermTech.
19:58 – Chinese regulatory risks.
22:29 – What is a stock?
24:15 – State of play for Xero.
25:25 – What do we look for in a company?
27:00 – Are we currently buying?
28:21 – Thoughts on the Redbubble quarterly results....
2021-04-2337 minFrazis Capital PodcastEpisode 42: Brian Hartzer, CEO of Westpac from 2014-2020, on leadership, culture and financial technologyBrian Hartzer joins us to talk about his new book 'The Leadership Star', available from Amazon.
Brian was CEO of Westpac from 2014-2020. For those who don't know Westpac is Australia's second largest bank with over $800 billion of assets.
Brian discusses his 'Leadership Star' framework and pivotal moments in Australia's banking history. Brian also shares his views on cryptocurrency, neobanks, alternative lenders, the Buy-Now-Pay-Later movement, and the future of financial technology more broadly.
Timestamps
00:05 – Introducing Brian
03:15 – Brian's new book: ‘The Leadership Star: A Practical Guide to Building Engagemen...
2021-04-0659 minFrazis Capital PodcastEpisode 41: Where to next? SPACs, rising interest rates and tech stocksMichael Frazis gives an update on SPACs, rising interest rates, tech valuations and what might happen next.
Timestamps
1:35 - Quick review of 2021
2:30 - Thoughts on Cathie Wood and ARK
3:59 - Expansions and contractions in software multiples
7:40 - Snowflake
8:47 - SPACs: why we like them and why they're dangerous (hint: the same reason)
12:02 - Why we hope SPACs encourage leading tech firms to list sooner
14:21 - Dodgy forecasts
16:51 - Why we rule out most SPACs in the fund
18:00 - Navigating rising interest rates
22:33 - The recent sell-off
24:32 - How we...
2021-03-2128 min
The Dental Head Start PodcastTIP#38: Making Decisions with Dr Michael Frazis
Welcome to What I Wish I Knew by Dental Head Start. This is a podcast where we learn from people that have been there, made the mistakes, learnt the lessons and have developed into the accomplished dental professionals they are today.
It’s your weekly mentoring session.
Patients come to us for guidance. However, early on in our career, making the decision between filling, inlay, onlay or crown can be a difficult call.
In this episode we chat with Dr Michael Frazis about this decision and the challanges he found with this early in...
2021-03-1823 min
Equity Mates Investing PodcastExpert Investor: Michael Frazis - Frazis Capital PartnersHere at Equity Mates, we love finding up and coming Australian fund managers that have interesting perspectives and different approaches to markets. In this episode we speak to Michael Frazis, portfolio manager of Frazis Capital Partners, who certainly fits that description.Michael has just come off an incredible year in 2020, beating his benchmark index by more than 100%! In this interview we unpack his unique investment philosophy, some of the companies that have driven his returns and his view on two sectors of particular interest to him - technology and life sciences. In this episode you w...
2021-03-0346 minFrazis Capital PodcastEpisode 40: GamestopJanuary 2021 - one of the more amusing weeks of finance.
0:57 - The short squeeze
2:31 - The reality of Robinhood's 'free' trades
5:08 - The hidden consequences of Hedge Fund strategy
6:51 - How useful is management access?
9:56 - The gamma squeeze
12:15 - How this forced people to rethink how they discuss finance?
13:39 - Is the squeeze squoze?
14:37 - Timing and recovery
15:40 - Our strategy
17:24 - An important dynamic of short interest
19:43 - The true signal of growth
20:32 - How fund managers missed a multidecade trend?
23:00 - A c...
2021-01-3025 minFrazis Capital PodcastEpisode 39: January 2021 Strategy Update1.40 - Quick review of 2020
2.35 - How to survive huge market swings like March 2020 and 2008-2009
3.45 - Discussion on support mechanisms in place in equity markets (central banks, fiscal stimulus, actions by management teams, etc)
5.45 - Current investment strategy is to stay invested & make sure we are constantly holding winners
7.35 - Sound fundamental reasons why companies with intense customer love, explosive growth, and market leadership perform so well
8.15 - Our companies are investing heavily. When revenue comes in they open new offices, hire marketing staff and etc which promises a great...
2021-01-2643 min2020-10-2742 minFrazis Capital PodcastEpisode 37: Jackie Vullinghs from AirtreeJackie Vullinghs @ Airtree
0:11 - Introducing Jackie
0:54 - University in Australia vs the UK
3:08 - Interviewing at Oxford and Cambridge
3:56 - Approach to VC interviews with company founders
5:55 - Jackie discusses AirTree's key portfolio focus (digital health, fintech, consumer)
6:48 - Companies are staying private for longer, is that good or bad?
8:38 - How sustainable are the accelerations of digital health and ecommerce?
9:57 - Low relative penetration of ecommerce in Australia
11:25 - Equity derivatives in London
13:39 - Jackie's shift to start-up, Listable, Kalo
14:50 - August tech runup & option trading
20:46...
2020-09-2559 minFrazis Capital PodcastEpisode 36: Jarred Shein joins us to talk digital healthJarred Shein joins us to talk digital health. Jarred has invested in digital health at MH Carnegie and Qure, an Israeli based VC fund.
0:20 - Introducing Jarred
1:00 - Jarred's education and background.
1:45 - Jarred's studies of nanotechnology, specifically biochemistry
2:30 - Jarred's thesis on biosensor devices and how it relates to Startrek
3:55 - End of university job with Macromatix, completely unrelated to biochemistry
5:10 - The early opportunity to pick up distressed medical device assets
6:00 - Australia's strong position in the world and relatively painless COVID-19 experience mak...
2020-09-2147 minFrazis Capital PodcastEpisode 35: Sam Rich joins us to talk security, Crowdstrike, travel names, and how we're positioning the portfolioSam Rich joins us to talk security, Crowdstrike, travel names, and how we're positioning the portfolio.
2020-09-0330 minFrazis Capital PodcastEpisode 34: Joel Tomaino joins usWe discuss the current landscape and a couple of choice earnings reports.
0:20 – Introducing Joel Tomaino
1:10 – The structural shift to e-commerce
1:30 – Government stimulus and the diverse impacts of the current economic crisis
2:30 – How long will stimulus benefits and exacerbated e-commerce growth rates last
3:30 – Australian e-commerce plays, including Redbubble (ASX:RBL)
4:40 – E-commerce growth in mature markets compared to developing markets
5:00 – The opportunity for MercadoLibre (NASDAQ:MELI) in South America
6:20 – The opportunity for Sea (NYSE:SE) in South-East Asia
6:55 – Disney’s powerful platform and the success story of...
2020-08-2718 minFrazis Capital PodcastEpisode 33: Interview with Chris Gosselin from Australian Fund MonitorsChris Gosselin from Australian Fund Monitors (https://www.fundmonitors.com/landing.php) interviewed us about the fund and strategy.
0:00 - Introducing Michael Frazis
1:12 - Michael introduces Frazis Capital and describes its core investment requirements (Customer love, explosive growth and market leadership)
2:45 - The opportunity presented by high growth companies with ugly financial statements, professional scepticism and high short interest
4:00 - The best investment opportunities are often in front of your eyes the entire time
4:35 - Michael reiterates the importance of the fund's core investment requirements
6:10 - Unit e...
2020-08-1922 minFrazis Capital PodcastEpisode 32: Peter Stevens joins us to discuss a new stock and our current outlookCompanies with brilliant products and broad customer support are faring significantly better than mature incumbents.
One of the fund's newest holdings satisfies our three core criteria: Exponential growth, products that customers truly love, genuine market leadership.
2020-07-1716 minFrazis Capital PodcastEpisode 31: Gaming, eSports and chipmakers - Ben Krochmal joins us for a deep diveGaming is one of the more exciting industries in technology right now. We discuss the opportunities and precedents for Twitch and streaming phenomenon.
Ben also takes us through leading chipmakers like NVDIA.
0:32 - Long term trends for Nvidia
2:16 - Demand for Nvidia GPU's in Data centres
3:03 - Use of Nvidia chips for Crypto mining
4:38 - Semiconductors are on the forefront for everything
5:46 - Nvidia compared to other chip makers, AMD and Intel
8:35 - Bitcoin mining economics
9:22 - Te...
2020-07-0743 minFrazis Capital PodcastEpisode 30: Plug Power, Solaredge, and a market updatePeter Stevens rejoins us to discuss some of our environmentally friendly investments.
0:30 - The continued dispersion between technology and the rest of the market
0:50 - The successes of Pinduoduo, Carvana and Afterpay
1:28 - Frazis Capital's successful diversification away from a highly concentrated portfolio
2:33 - Comparing today's hot tech businesses with the hot auto businesses of the past
3:00 - Michael introduces Plug Power (NASDAQ:PLUG), a hydrogen fuel cell manufacturer and one of the fund's most exciting holdings
5:00 - Introducing the Frazis Capital Youtube channel
2020-07-0516 minFrazis Capital PodcastEpisode 29: Alexander Portz joins us to talk growth investing in the UK and abroadAlexander began his career investing in technology for UK funds management giant Neptune, before joining London-based VC fund Redline Capital. It's rare indeed to speak to someone with experience across the public and private side of tech investing.
We had a fascinating chat covering robotic process automation, innovation investing, and life in venture capital vs public markets.
https://www.linkedin.com/in/alexander-portz-3a265236/
https://www.redline-capital.com/
0:50 - Alex talks about his start in public markets
2:30 - Tech investing at Neptune Capital
3:50 - Alex discusses a high-performing company du...
2020-06-1057 minFrazis Capital PodcastEpisode 28: Moving up against the marketEti Amegor of Axius Partners & www.suitsandkicks.com joins us to talk allocating and investing in the strange current environment.
0:52 - Opportunities during the coronavirus
1:55 - Current investor trends regarding liquidity
3:30 - The new private equity fund being launched by Eti's firm
6:30 - Why the coronavirus is the best environment for active investment managers
8:00 - Life Sciences stocks and the coronavirus
9:30 - Mike talks through Moderna, which focuses on drug discovery and development based on messenger RNA
10:50 - Eti and Mike talk Afterpay (again)
14:00 - The endgame... Afterpay vs Paypal
2020-05-1655 minFrazis Capital PodcastEpisode 27: Coronacrisis Recovery?Peter Stevens joins us once again - and will upload notes for this shortly.
2020-04-1742 minFrazis Capital PodcastEpisode 26: Deeper into the coronacrisisMichael Frazis and Peter Stevens discuss the latest developments.
2020-04-1048 minFrazis Capital PodcastEpisode 25: Market sell-off and interesting timesPeter Stevens joins us to talk about the market sell-off, how we're positioned, and interesting opportunities that we've found.
If you'd like to know more about us see:
www.fraziscapitalpartners.com
Peter writes his own market commentary here:
https://insufficientcapital.com/
0:24 – Peter wipes away his tears
0:50 – There’s growth and then there’s growth (e.g. Afterpay vs Zip)
1:30 – Why you should pay up for quality businesses
2:17 – Illiquidity during sell-offs
2:50 – Electro Optic Systems (ASX:EOS), a great business that does not fit ESG criteria...
2020-03-0925 minFrazis Capital PodcastEpisode 24: Coronavirus - what's going on? Claude joins us to talk about the impact on specific stocks, and we also cover Afterpay's resultsThree things you didn't know about the the virus, an Aussie company that stands to benefit, and two in the United States. Afterpay's results... this was a quick one, but a good one.
If you'd like to know more about us see:
www.fraziscapitalpartners.com
You can find Claude at
www.arichlife.com.au
0:50 – Michael gives an update on the underlying science of the latest coronavirus
1:44 – The importance of understanding the spike protein
2:05 – Why the coronavirus is so much more infectious than SARS
3:14 – Claude shares hi...
2020-02-2824 minFrazis Capital PodcastEpisode 23: Time to sell? Mike and Claude go through Shopify, EML and other cult stocks in the market right nowEpisode 23: Time to sell? Mike and Claude go through EML, Shopify, Wisetech and other cult stocks in the market right now.
If you'd like to know more about us see:
www.fraziscapitalpartners.com
1:08 - Michael and Claude discuss EML Payments (ASX:EML)
1:44 - The ethical dilemma of EML’s gambling exposure
2:40 - Problems relating to the sale high growth stocks
3:16 - EML’s acquisition of Prepaid Financial Services
3:44 - Accusations from Ownership Matters concerning EML
6:50 - The issue with ‘EBITDA’ as a financial metric
9:05 - Michael and Peter St...
2020-02-2544 minFrazis Capital PodcastEpisode 22: Aussie growth stocks for the next decade? Mike and Claude talk Polynovo, Avita, Audinate, Pro Medicus and AfterpayMike and Claude from A Rich Life (https://arichlife.com.au/) talk Australian growth stocks for the next decade.
If you'd like to know more about us see:
www.fraziscapitalpartners.com
0:38 - Claude's background and time at Motley Fool
4:30 - Pro Medicus (PME:ASX) recommendation and discussion
6:38 - Claude touches on his investment style
8:08 - Pro Medicus as a platform business rather than just a software business
8:30 - Pro Medicus - the numbers
10:20 - Claude dives into Pro Medicus' two key revenue streams
11:50 - Michael introduces Alteryx (A...
2020-02-1649 minFrazis Capital PodcastEpisode 21: A high-tech company with explosive growth...and various other science things you don't want to missMatthew Shribman has accumulated over 25 million views across platforms for his 'Science in the Bath' series, available here: https://www.youtube.com/channel/UCoSRNBi6F4jN0CYq-sRcOHQ
We talk about how birds literally 'see' the Earth's magnetic field, and cover Twist Bioscience, a company that's revolutionizing gene synthesis. Twist is working on DNA as a viable storage medium for computers, drug discovery, genetic sequencing and synthetic biology. This is a little more sciencey than usual, but I think you will enjoy!
If you'd like to know more about us see:
www.fraziscapitalpartners.com
2020-02-1245 minFrazis Capital PodcastEpisode 20: Australian bushfires, and two Aussie companies revolutionising burns treatmentPeter Stevens joins us to discuss Coronavirus and two Aussie burns innovators: Avita and Polynovo. Find more information about us here: www.fraziscapitalpartners.com And please get in touch if you have questions you'd like us to answer on the podcast, suggestions or feedback.
If you'd like to know more about us see:
www.fraziscapitalpartners.com
00:28 – Coronavirus, and how to calculate the real mortality rate
02:20 – The common cold is a coronavirus
04:18 – Market performance during past pandemics
05:00 – Why you shouldn’t sell your stocks because of the coronavirus!
07:00 – Au...
2020-02-0532 minFrazis Capital PodcastEpisode 19: How we’re differentPeter Stevens rejoins us to discuss investment strategy and our top new picks.
If you'd like to know more about us see:
www.fraziscapitalpartners.com
1:00 – Recap of 2019; how shorts hampered performance and the stocks that went well
3:58 – Why doing less is a key lesson
5:58 – Where Frazis Capital sits in portfolios
8:06 – How companies like Xero and Afterpay shot the lights out and how investors can find the next 20-baggers
14:14 – Michael Frazis’s background
17:30 – The only ‘real way’ to make money
18:46 – 3 most exciting companies in the Fraz...
2020-02-0428 minFrazis Capital PodcastEpisode 18: Portfolio updates and new ideas with Peter StevensPeter Stevens joins us to talk about some of our long held investments and latest new ideas. Peter Stevens has rejoined Frazis Capital Partners, and writes his own market blog here: https://insufficientcapital.com/
If you'd like to know more about us see:
www.fraziscapitalpartners.com
2019-12-2042 minFrazis Capital PodcastEpisode 17: Strategy, biotech and growth investing with Eti AmegorA wide-ranging conversation with Eti Amegor, of Axius Partners.
We discuss growth investing, Carvana and our top biotech picks, including a drug to reduce stress.
Eti runs a podcast himself and asked some tough questions! This one was a lot of fun.
Eti's podcast 'Suits and Kicks' is available here: https://podcasts.apple.com/au/podcast/suits-and-kicks/id1454889632
If you'd like to know more about us see:
www.fraziscapitalpartners.com
2019-11-291h 12Frazis Capital PodcastEpisode 16: Paul Brennan goes deep on the Australian economyPaul Brennan is a markets veteran with over 20 years at Citigroup in Australia, most recently as Chief Economist. He now consults for a wide range of clients, and in his spare time, offers his expertise to university students. It's always great to have a chat with someone who measures their market experience in decades, so this was a real privilege. We go deep on economics, the Australian economy, what it was like in the 90s and where things might be going next.
If you'd like to know more about us see:
www.fraziscapitalpartners.com
Pa...
2019-11-0850 minFrazis Capital PodcastEpisode 15: Growth opportunities and the software sell-off with Peter StevensPeter Stevens joins us to talk about the recent growth sell off and the new opportunities and investment ideas we're looking at.
If you'd like to know more about us see:
www.fraziscapitalpartners.com
2019-10-2943 minFrazis Capital PodcastEpisode 14: Value is Dead, Long Live Value with Mario EmmanuelThere are many ways to create value without showing after-tax profits.
Michael Frazis and Mario Emmanuel discuss new approaches.
https://www.fraziscapitalpartners.com/post/value-is-dead-long-live-value
2019-10-1242 minFrazis Capital PodcastEpisode 13: A chat with Anna Satouris about energy, markets and pricesRecorded 16 September, 2019, this podcast features Anna Satouris and a discussion around energy, markets and prices.
2019-09-2316 minFrazis Capital PodcastEpisode 12: We discuss a strong reporting season and our fee rebate to long term clientsMichael Frazis and Anna Satouris discuss Carvana, Afterpay, Pinduoduo and our recent fee rebate to long term clients.
2019-08-3024 minFrazis Capital PodcastEpisode 11: Rebecca Gingell on alloy design and OxMet, an Oxford University spinoutThis episode features a chat with Rebecca Gingell, who runs business development at OxMet Technologies, an Oxford University spin-out utilizing decades of academic modelling expertise to design and commercialize new alloys.
It turns out that almost every alloy we use in every day life was discovered long ago.
Rebecca explains how we've barely scratched the surface of the potential number of alloys, and shares some interesting facts, like why it's not actually strength that you should optimise for when designing medical alloys for bone implants.
More information on OxMet is available here:
htt...
2019-07-1846 minFrazis Capital PodcastEpisode 10: Computing with live neurons - Clinicloud founder takes us through his latest ventureIn this episode we recorded a fascinating chat with Hon Weng Chong, the founder CC Labs.
Hon Wen first rose to fame as a cofounder of Clinicloud, an innovative medical devices company that won FDA approval.
The firm was originally backed by Tencent and Ping An, and is now developing a new form of computing: instead of using silicon chips, they are growing live self-organising networks of neurons. They're not simulating neurons, they're actually growing them.
The technology could be applied to some of the toughest targets in artificial intelligence...
2019-05-2859 minFrazis Capital PodcastEpisode 9: We go deep with Eti Amegor on innovation, disruption and the role of hedge funds in a portfolioIn this episode we have a chat with Eti Amegor, director of Axius Partners and founder of Suits and Kicks ( http://www.suitsandkicks.com/ ).
At Axius, Eti advises and raises capital for some of the most distinguished and highest returning investment funds in the world.
We discuss innovation and disruption in technology, and the role of hedge funds in a portfolio.
2019-05-1835 minFrazis Capital PodcastEpisode 8: A conversation with Anna Satouris on Disney's new streaming service and portfolio protectionWe discuss the market outlook, Disney's new streaming service and portfolio protection.
2019-05-1219 minFrazis Capital PodcastEpisode 7: Michael Wayne and Michael Frazis discuss Medallion, markets, Alzheimers and biotechMichael Wayne is the founder of the Medallion Financial Group, a wealth management firm specialising in investment advice.
Michael discusses his firm, some investment ideas, and the outlook for financial markets, as well as Biogen's latest Alzheimer's trial failure in biotech land.
More information on Medallion and Michael Wayne can be found here:
https://www.medallionfinancial.com.au/
2019-04-0123 minFrazis Capital PodcastEpisode 6: Google, Carvana and IPG Photonics, a discussion with Harvey MigottiMichael Frazis and Harvey Migotti discuss Google, IPG Photonics and Carvana.
Harvey has a background in both public and private market investing, with roles at Balyasny, Amiya and Apax.
https://www.fraziscapitalpartners.com/
2019-03-1838 minFrazis Capital PodcastEpisode 5: Mike and Mario discuss some new investment ideasState of technology, famous investors, and some ways to hedge against turbulent times.
2019-03-0521 minFrazis Capital PodcastEpisode 4: Mike and Eti Amegor discuss volatility, real estate and how local investors are currently allocatingMichael Frazis and Eti Amegor go deep into volatility, why the beginning and end of 2018 were so different, and where Australian investors are putting their money.
Eti also talks about his blog Suits and Kicks, for high achieving professionals who want to perform at the highest level both inside and outside the office.
Available here:
http://www.suitsandkicks.com/
2019-02-1942 minFrazis Capital PodcastEpisode 3: Fiat, value, and the Aussie dollarMichael and Mario discuss Fiat, cyclicals, value, and Aussie fundamentals.
2019-02-1520 minFrazis Capital PodcastEpisode 2: Afterpay, Cooper Energy, Stanmore Coal and the Australian Housing MarketMichael Frazis and Anna Satouris discuss Afterpay, Cooper Energy, Stanmore Coal and the Australian housing market.
2019-02-1320 minFrazis Capital PodcastEpisode 1: Rundown of 2018 and a review of some of our US tech investmentsMichael Frazis and Mario Emmanuel discuss financial markets in 2018, the current outlook, and some of our latest investments.
2019-01-3136 min